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Abstract
Synovial joint morphogenesis occurs through the condensation of mesenchymal cells into a non-
cartilaginous region known as interzone, and the specification of progenitor cells that commit to 
the articular fate. Although several signaling molecules are expressed by the interzone, the 
mechanism is poorly understood. For treatments of cartilage injuries, it is critical to discover the 
presence of joint progenitor cells in adult tissues and their expression gene pattern. Potential stem 
cells niches have been found in different joint regions, such as the surface zone of articular 
cartilage, synovium and groove of Ranvier. Inherited joint malformation as well as joint 
degenerating conditions are often associated with other skeletal defects, and may be seen as the 
failure of morphogenic factors to establish the correct microenvironment in cartilage and bone. 
Therefore, exploring how joints form can help us understand how cartilage and bone are damaged 
and to develop drugs to reactivate this developing mechanism.
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Formation and positioning of synovial joints are critically important during evolution 
allowing successful adaptation of vertebrate limbs to a variety of ecological environments. 
Because of the variety of tissues comprising the synovial joint (articular cartilage, synovial 
fluid, ligaments, joint capsule) disease or trauma affecting one tissue has wide-ranging 
implications on the health and function of the joint as a whole organ (1). Inherited joint 
malformations, although relatively rare, present with a wide range of forms and severity and 
are often associated with skeletal defects, suggesting a reciprocal cause/effect relationship 
(2, 3). On the other hand, degenerating conditions that affect joint function, such as 
osteoarthritis (OA) and inflammatory rheumatoid arthritis (RA), are the single largest cause 
of disability in the adult population (4, 5), and while our understanding of the pathology of 
these diseases has greatly improved, the only successful treatment for restoring joint 
function in end-stage diseases is total joint replacement (6). To some extent, this lack of 
effective medical treatments is due to the fact that the articular cartilage is avascular, and 
this limits its reparative capacity (7). Although physiologically and clinically significant 
there is limited information on the mechanisms and signaling molecules that lead to joint 
morphogenesis. A greater understanding of joint formation can provide critical insight on 
the pathogenesis of joint degeneration and to develop novel reparative strategies to restore 
long-term joint function following trauma and disease.
JOINT MORPHOGENESIS
During skeletogenesis, long bone formation initiates as uninterrupted mesenchyme 
condensations in the early limb buds, which undergo differentiation to chondrocytes (1, 6). 
Joint formation becomes morphologically evident with the appearance of a region called the 
interzone at the sites of future joint location where the resident cells flatten and form a clear 
separation of the previous uninterrupted cartilaginous skeletal anlagen (8–9). In most 
species, the interzone is a tripartite structure consisting of two outer layers adjacent to the 
epiphyseal end of the future bones and an intermediate zone, that adopt a nonchondrogenic 
phenotype, as indicated by the loss of chondrogenic markers such as Sox-9 and Collagen 2, 
and the expression of new sets of genes including Gdf5, Wnt14 and Wnt4 (10–12). The 
pivotal role the interzone in joint formation is widely recognized, as its microsurgical 
removal results in joint ablation (8–9, 13). Ultrastructural analysis in developing rat embryos 
indicated that the outer interzone layers participate in initial lengthening of long bone 
anlagen, while articular chondrocytes largely derive from the intermediate layer (14). 
Despite wide recognition that the interzone region is essential for joint formation, there is 
limited information of the gene expression environment in which interzone cells emerge and 
distinguish themselves from adjacent growth plate chondrocytes (14–16). Numerous studies 
in recent years have reported several signaling molecules, growth factors, transcription 
factors, and other regulatory molecules expressed by the interzone: these include GDF-5, 
Wnt-14, Wnt-4, Wnt-16, Gli3, CD44; BMP antagonists Chordin and Noggin; fibroblast 
growth factor family member FGF-2, FGF-4 and FGF-13; transcription factors Cux1 and 
ERG (10, 12, 17–20). GDF-5 is expressed in the early interzone in mouse and chick embryo 
limb joints and lack of GDF-5 in the natural mouse mutant brachypodism, causes 
widespread joint defects and skeletal growth retardation (21). Subsequent studies established 
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that Gdf-5-expressing cells give rise to most if not all joint tissues, including articular 
cartilage, ligaments and inner synovial lining (14). The current view is that GDF-5 has at 
least two roles in skeletogenesis. At early stages, it is expressed throughout the condensation 
and would stimulate recruitment and differentiation of chondrogenic cells. At later stages, 
when its expression becomes restricted to the interzone, GDF-5 would promote interzone 
cell function and joint development (22). Iwamoto et al. reported that there is a close 
spatiotemporal expression of GDF-5 with the transcriptional factor ERG (one of the ets gene 
family member) in developing mouse embryo joints which suggests that ERG acts 
downstream of GDF-5 leading chondrocytes to become joint forming cells (9).
Wnt14 and the BMP antagonist Noggin are anti-chondrogenic factors that are expressed 
early during interzone formation. Targeted misexpression of Wnt14 in developing chicken 
digit rays induced ectopic joints, with upregulation of Gdf5, Wnt4, CD44 and down-
regulation of Col2, Sox9 (10) while ablation of Wnt-14 along with Wnt-4 impairs joint 
formation and causes some fusions (23). In vitro studies show that Wnt14 reversed 
chondrocyte differentiation in predifferentiated micromass culture, reflecting what happened 
in vivo(10, 24).
Experimental ablation of Noggin in mouse prevents limb joint formation and causes skeletal 
fusions (17). The role of Noggin is conserved between mouse and humans, and at least two 
human syndromes, which are characterized by multiple synostoses (absence of joints), are 
due to mutations in Noggin (25). The expression of another BMP antagonist, Chordin, is 
restricted to the joint interzone, emphasizing the role of BMP antagonism during joint 
development. The significant concept stemming from these studies is that joint formation 
involves the intervention of gene products with chondrogenic and anti-chondrogenic 
activities, the former critical for formation of fibro-cartilaginous joint structures and the 
latter for maintaining the initial mesenchymal character of cells present at joint sites (15). 
Thus, it is not surprising that the joint interzone appears to be also an essential regulator of 
skeletal development, and vice-versa (24). One example is shown by the conditional 
inactivation of Ext1 in developing joints in Gdf5-expressing cells. Ext1 encodes a subunit of 
the Ext1/Ext2 Golgi-associated protein complex responsible for heparan sulfate (HS) 
synthesis. Heparan sulfate (HS) is an essential component of cell surface and matrix-
associated proteoglycans and mutations in HS-synthesizing and modifying enzymes cause 
several skeletal phenotypes, such as hereditary multiple exostoses (HME), described later in 
joint genetic disease chapter. Interestingly, mutation of Ext1 in Gdf5-expressing cells, led to 
lack of a distinct mesenchymal interzone with consequent joint fusion. They also found 
abnormal BMP and hedgehog activity and signaling leading to a delayed growth and 
lengthening of long bones indicating that defects in joint formation reverberate on, and 
delay, overall long bone growth (26).
Recent studies have identified an important role for HIF-1 and HIF-2 in the regulation of 
skeletal development as well as joint formation and homeostasis. In addition, overexpression 
of HIF-1 and HIF-2 has been clinically associated with osteoarthritis (27).
The critical role of Ihh and parathyroid Hormone-Related protein (PTHrP) during 
endochondral bone formation is well known, but also their importance in synovial joint 
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formation (28–30) has been reported. Ihh null have mice failed joint development (28, 31, 
32) and have abnormal distribution and function of Gdf5-expressing interzone-associated 
cells (17, 29, 31, 33). These studies suggest that in the developing diaphysis, secreted Ihh 
could diffuse and reach the epiphyseal ends of the long bone analgen, where it would 
regulate interzone formation (1). Using a PTHrP-Lac-Z knockin mouse containing a β-gal 
reporter under endogenous PTHrP gene regulatory sequences, Chen et al. have confirmed 
two distinct PTHrP β-gal positive subpopulations: in the articular cartilage and in the 
proliferative chondrocytes, that are maintained through adulthood (34) (35). A role for 
PTHrP in articular cartilage maintenance has been recently proposed by Gdf5-Cre-targeted 
knock-down of PTHrP in mouse articular chondrocytes that led to accelerated development 
of OA in a DMM model (36). In addition, systemic administration of recombinant human 
PTH in mice inhibited cartilage degeneration and induced cartilage regeneration following 
meniscal/ligamentous injury (37).
Proper spatial positioning of synovial joints is crucial in skeletogenesis. Sohaskey et al. 
reported that mice carrying an insertional mutation in the Jaws gene (abnormal joint with 
splitting) die perinatally with striking skeletal defects, including ectopic interphalangeal 
joints (38). These ectopic joints develop along the longitudinal axis and persist at birth, 
suggesting that JAWS is uniquely required for the orientation and consequent positioning of 
interphalangeal joints within the endochondral skeleton.
Transgenic mice overexpressing fibroblast growth factor receptors (FGFR) 1 and 3 exhibit 
joint defects similar to the symphalangism that occurs in Apert syndrome, a rare congenital 
disorder characterized by craniosynostosis, midfacial malformation and symmetrical 
syndactyly. In this mice some synovial joints failed to develop and the presumptive joint 
space was replaced by cartilage. (39)
A recent study by Gao et al. reported a critical role of Osr1 and Osr2, the mammalian 
homologs of the odd-skipped family of zinc finger transcription factors required for 
Drosophila leg joint formation, in mouse synovial joint formation. They report that Osr1 and 
Osr2 and are both strongly expressed in the developing synovial joint cells and are required 
for Gdf5, Wnt4 and Wnt14 expressions (40).
Genetic manipulation of the TGF-β system has revealed critical roles in both joint 
development and skeletogenesis (41–43). In transgenic mice, overexpression of a dominant 
negative Tgfbr2 (DNIIR) resulted in OA(40). In humans, mutations of the Tgfbr2 have been 
associated with Loeys-Dietz syndrome, a Marfan-like syndrome that leads early onset of OA 
(OMIM#609192) (44,45). In previous studies, by generating a TGF-β type II receptor 
(TβRII) reporter mouse (β-Gal and GFP), we showed that TβRII is highly and specifically 
expressed in the developing joint (43). By generating a mouse in which the TβRII signaling 
is conditionally inactivated in mesenchyme limb buds starting at E9.5 (Tgfbr2Prx1KO), we 
demonstrated that the lack of TβRII signaling led to complete absence of interphalangeal 
joints and was associated with down-regulation of key joint morphogenic factors (such as 
Noggin, GDF5 and the Notch ligand, Jagged 1). Interestingly, lack of joint was associated 
with up-regulation of many inflammatory cytokines/chemokines in the presumptive 
interzone, such as MCP-5 and Il 36 (43, 46, 47); blockade of MCP-5 receptor was able to 
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rescue the TβRII-mediated joint deficiency (47), suggesting that cytokines/chemokines may 
have a regulatory role during development, mediating proper interzone formation.
There is compelling evidence that Notch signaling is critical for progenitor cell survival and 
for their maintenance in an undifferentiated state, which sets the boundaries that segregates 
two distinct cell populations during development (48–52). Notch1 is a regulator of great 
importance for cell fate commitment during both early growth and in adult tissues and has 
been shown to play a critical role in the cell fate determinant in different stem cell niche 
structures such as the skin, teeth and nervous system (53). Hayes et al. reported that Notch 1 
is expressed in the developing and post-natal articular surface (54). The Notch family 
members are also expressed in adult articular cartilage (55) and over 70% of chondrocytes 
on the surface zone of articular cartilage express Notch 1 receptor (16), suggesting a 
significant role of the Notch signaling in regulating articular cartilage homeostasis during 
adult life (55,56)
Despite important advances on multiple fronts, there are still fundamental aspects of joint 
formation that remain unclear and in particular, how joints acquire their diverse morphology 
and organization from embryonic life to adulthood. A better understanding of genes 
involved in patterning processes will be critical to link embryonic development with joint 
disease in adult, in both inherited and acquired debilitating diseases.
PROGENITOR STEM CELL NICHE
The view of articular cartilage as a non-regenerative organ has been challenged in recent 
years. The superficial zone of articular cartilage demonstrates a distinct pattern regarding 
stem cell markers (Notch-1, Stro-1, and vascular cell adhesion-1) (57) and has been 
hypothesized to harbor stem cells (58). Studies regarding cartilage development have shed 
light on the question of whether any of the joint tissues harbors potential joint progenitor 
cells. Through the use of BrdU (bromo-deoxyuridine) injections to localize slow-cycling 
cells, a trait characteristic of progenitor cells, a few potential joint stem cell niches have 
been determined. A Notch-1 positive cell population has been isolated from the surface zone 
of articular cartilage (59); these cells possess high colony-forming efficiency that was 
abolished when Notch signaling was blocked (16).
Karystinou et al reported the isolation and characterization of multipotent MSCs from adult 
human synovium, that could be expanded for up to 30 population doubling, with limited 
senescence and maintenance of multilineage differentiation capacity toward chondrogenesis, 
osteogenesis, adipogenesis and skeletal myogenesis (60). In response to injury of various 
types, including trauma, the synovial membrane rapidly becomes hyperplastic, which seems 
to be sustained mainly by stromal synovial fibroblasts (61–63). The biologic function of 
synovial cell proliferation is believed to have a pivotal role in joint homeostasis and 
deregulation of this process is thought to contribute to the formation of pannus, which in RA 
causes destruction of cartilage and bone (63). Although very little is known about the 
identity of the synovial cells that proliferate following injury, this study provides the first 
evidence of the existence in vivo, within postnatal knee synovium, of non-hematopoietic, 
non-endothelial stromal cells with MSC phenotype (64–66) which proliferate following 
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articular cartilage injury and, under specific experimental conditions, differentiated into 
chondrocytes in area of cartilage metaplasia within the synovium (67).
An area of potential interest with regard to joint progenitor cells is the perichondrial groove 
of Ranvier. This area is located at the periphery of the epiphyseal growth plate and has been 
demonstrated to contain proliferating cells (68). Studies by Karlsson et al. in the knee of 
sexually mature rabbits have proved the existence of different subpopulations of progenitor 
cells, in the articular cartilage, in the groove of Ranvier, as well as the epiphyseal plate near 
the groove of Ranvier; however, whereas the progenitor cells in the surface layer of the 
articular cartilage seem to lose their progenitor properties and become dispersed throughout 
the articular cartilage as they grow older, the progenitor cells in the groove of Ranvier were 
positive for several marker associated with stem cell niche (including Stro-1, Jagged-1 and 
BMPr1a) and maintain their progenitor properties and localization over time (58).
We have addressed in the previous section the critical role of the TβRII in joint-element 
development. Our finding that mice lacking of TβRII signaling in developing limbs failed 
interzone formation and lacked interphalangeal joints, led us to investigate the expression 
pattern of TβRII-expressing cells and their characterization as joint progenitors(69) By using 
a Tgfbr2-β-Gal-GFP-BAC mouse previously described, we have recently characterized the 
TβRII-expressing cells as joint progenitors(69), clustering in a contiguous niches that 
comprises the groove of Ranvier and the synovio-entheseal complex, including part of the 
perichondrium, the synovium, the articular cartilage superficial layer and the tendon’s 
enthuses(69) Developmental-stage studies showed that TβRII expression was in synchrony 
with expression of joint-morphogenic genes such as Noggin, Gdf-5, Notch1 and Jagged1. 
Pre-natal and post-natal BrdU-incorporation studies showed that within this synovio-
entheseal articular cartilage niche most of the TβRII-expressing cells exhibit stem cell traits. 
In addition, TβRII-expressing cells isolated from embryonic limb mesenchyme expressed 
joint progenitor markers in a time- and TGF-β-dependent manner. TβRII-expressing cells 
were maintained in their specific niches from embryonic life throughout early adulthood, 
although characterized by a progressive age-dependent reduction in number.
The functional characterization of adult joint progenitors, together with the identification of 
embryonic markers that are preserved in postnatal joints, opens prospects for potential ways 
to reactivate the joint-forming ability of such cells, to implement their survival during aging 
and to evaluate their role in joint genetic disease as well as joint degenerative pathologies, 
such as arthritis.
JOINT GENETIC DISEASES
Genetic constitution is a factor in the development of most diseases, including those of 
bones and joints. Evidence for the influence of genes in most disease development is 
expressed in two ways. In polygenic disorders, the genetic influence is indirect, based only 
on the higher rate of recurrence in some families compared to the general population. The 
second group follows Mendelian inheritance, where a specific gene is directly responsible 
for the disease and the gene is passed on to subsequent generations. These diseases may also 
appear spontaneously as new mutations. There are over 5000 documented Mendelian 
disorders, and over 500 of these affect bones and joints (70). Some of these single gene 
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disorders affect many tissues, and the skeletal system, including joints, is one of many 
organs involved (71), others are directly related to joint malformation. It is beyond the scope 
of this review to give a detailed list of all the joint genetic diseases; however, we will 
provide some examples in Table 1. There are very few genes that are known to be necessary 
and/or sufficient to initiate the joint formation process, among them Noggin, Gdf5, Tgfbr2 
and Wnt14 (10,17,22,41). The factor(s) that induce the expression of these joint 
morphogenic molecules are undefined. Gong et al. (25) demonstrated that five dominant 
mutations in the Noggin gene in unrelated families segregate with proximal symphalangism 
(SYM1A, OMIM#185800), an autosomal dominant disorder characterized by a complete 
bony fusion between the proximal and middle phalanges of the digit. Another form of 
proximal symphalangism (SYM1B) is caused by a heterozygous missense mutation in the 
Gdf5 (OMIM #615298).
We reported that TβRII functions as a master regulator for the expression of key joint 
marker genes, such as Gdf5 and Noggin, and is necessary for proper joint development (43). 
The joint phenotype observed in mice lacking the Tgfbr2 gene in limbs is similar to that in 
patients with SYM1. In humans, heterozygous mutations of the Tgfbr2 gene have been 
associated with Loeys-Dietz syndrome (OMIM #610168), a Marfan-like syndrome 
characterized by several defects including joint hypermotility and/or contractures that lead to 
early onset of OA (44,45). It has been hypothesized that in Loeys-Dietz syndrome, an excess 
of TGF-β signaling accounts for the pathological manifestations (72).
Several lines of evidence have demonstrated the importance of Notch signaling in joint 
morphogenesis and genetic inactivation of the Notch signaling in Drosophila, resulting in 
loss of joints (73). A derangement of Notch signaling has been reported in articular 
synoviocytes from patients with RA, characterized by aberrant synoviocyte proliferation 
(74). Heterozygous mutation in the Notch2 gene causes the Hajdu-Cheney syndrome 
(HJCYS, OMIM #102500), a rare autosomal dominant disorder that, in addition to severe 
skeletal abnormalities including acroosteolysis, is characterized by joint laxity. Mutations 
and deletions in Jagged-1 (Notch ligand) have been found in patients with Alagille 
syndrome characterized by intrahepatic cholestasis, eye and cardiac abnormalities, as well as 
skeletal defects in particular in the fingers (75, 76).
Mouse studies have indicated that embryonic long bone development is altered by mutations 
in Ext genes members (Ext1, Ext2 and Ext3) of the exostosin protein family and responsible 
for the synthesis of heparan sulphate (HS)(77). Recent data have shown that loss of Ext-1 
expression postnatally is not only affecting the growth and organization of long bones, but is 
incompatible with normal joint structure, resembling human OA (78, 79). In humans, HS 
deficiency due to mutation in the genes encoding exostosin-1, -2, -3, causes multiple 
hereditary exostoses (EXT, OMIM #133700), an autosomal dominant disorder characterized 
by multiple projections of bone capped by cartilage, most numerous in the metaphyses of 
long bones, but also occurring on the diaphyses of long bones. Deformity of the legs, 
forearms (resembling Madelung deformity), and hands is frequent (80).
Mutations in the Jaws gene (joints abnormal with splitting), also known as Impad1 (inositol 
monophosphatase domain-containing protein 1) cause the GPAPP type of chondrodysplasia 
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with joint contractures, an autosomal recessive disorder characterized by short stature, 
chondrodysplasia with brachydactyly, congenital joint dislocations, micrognathia, cleft 
palate, and facial dysmorphism (OMIM #614078).
Alkaptonuria (AKU, OMIM #203500) is an autosomal recessive metabolic disorder caused 
by homozygous or compound heterozygous mutations in the homogentisate 1,2-dioxygenase 
gene (HGD) and characterized by accumulation of homogentisic acid, leading to darkened 
urine, ochronotic pigmentation of fibrous tissues including cartilage, tendons, ligaments, 
chronic joint pain, and destruction of the cardiac valves. Ultimately, patients develop severe 
secondary OA.
Current knowledge of joint biology and pathologies has not been translated, however, into 
effective therapies to treat joint conditions (103, 104). Knowing how joints form during fetal 
life, express certain genes that become established in early post-natal life and are maintained 
in adult life would shed light on the homeostasis of the whole joint and could lead to novel 
treatment for many joint disorders.
CAN WE UNDERSTAND BETTER OA FROM JOINT DEVELOPMENT?
OA is a complex disease caused by the interaction of multiple genetic and environmental 
factors and the major cause of disability in the adult population. Although articular cartilage 
degeneration is the primary concern in OA, it is now the prevailing paradigm that OA is a 
disease of the entire joint and homeostasis and integrity of articular cartilage depends also 
on the biochemical interplay with subchondral bone; thus, it not surprising that mutation in 
genes that are needed during skeletogenesis may lead to OA later in life.
We have addressed the critical role of the TGF-β system in both joint development and 
skeletogenesis (41–43). The scope of this section is to provide an example of how genes that 
are so critical in joint morphogenesis may also have key roles in joint degenerating disease, 
such as OA. TGF-βs bind to TGF-β type II receptor (TβRII) leading to TβRII-TβRI complex 
formation, which then activates the signaling cascade through R-Smad dependent (Smad-2, 
-3,-4) and Smad-independent pathways (81, 82).
In human and mouse embryonic cartilage, TGF-βs are expressed in the endochondral 
template (83–86). Using laser capturing microdissection (LCM) we have obtained RNA 
samples from E13.5 progenitor joint-forming interzone cells and from the adjacent growth 
plate chondrocytes. Each population-related mRNA was subjected to microarray analysis. 
We have found that Tgfbr2 expression was 12.3 times higher, while Tgfbr1 and Tgfbr3 were 
slightly lower in the interzone cells. In mice, targeted manipulation of the TGF-β system 
genes have revealed their critical, but still undefined, function in skeletogenesis (41, 42, 87, 
88). R-Smad gene targeting in mice has led to variable phenotypes ranging from early 
lethality (Smad2 and Smad4 ablation) to a normal phenotype at birth with progressive OA in 
adulthood (Smad3 ablation) (89–92). In transgenic mice, overexpression of a dominant 
negative Tgfbr2 (DNIIR) can result in OA in adults (42); in chick embryos, however, 
implanted beads releasing TGF-β induce extra digit formation (93). In humans, mutations of 
the Tgfbr2 have been associated with Loeys-Dietz syndrome (44, 45, 72).
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In previous studies, we demonstrated that lack of TβRII signaling in developing limbs was 
associated with complete absence of interphalangeal joints as well as with impaired growth 
plate development (43).
By combining LCM with microarray analysis we were also able to show that interzone cells 
express a gene pattern that is distinct from adjacent growth plate chondrocytes and such 
gene regulation is impaired in mutant limbs lacking TβRII. We performed a pathway 
analysis using the PANTHER (protein analysis through evolutionary relationships) 
Classification System (Celera) to classify genes into canonical pathways. This enabled us to 
identify functional categories in the joint-forming interzone cells of wild type mice that were 
different from mutants. We determined that in the interzone cells the “inflammation 
mediated by chemokines and cytokines” was the most down-regulated pathway in the wild 
type interzone compared to mutant. Specifically, we found that monocyte chemoattractant 
protein-5 (MCP-5) and Interleukin 36-α (IL-36α) were among the most down-regulated 
genes in this pathway (46, 47). It has been reported that MCP5, MCP-1 and their sole 
common receptor CCR2, as well as IL-36α are increased in the inflamed joints of patients 
with different forms of arthritis and in rodent models for arthritis (94–97). While the role of 
inflammatory cytokines in the arthritic process appears indisputable, their role in joint 
development has never been evaluated. A finding of cytokine involvement in joint formation 
would determine a shift in our current view of joint cells as passive victims of the disruptive 
force of cytokines but as active participants in maintaining control of the cytokine effects 
and therefore joint integrity. It has been shown that in healthy cartilage, a balance between 
cytokines and anabolic growth factors is critical to maintain proper tissue homeostasis (98, 
99). Supported by our previously published data and other current evidence, in Figure 1 we 
propose a model for the role of TβRII signaling in regulating cell commitment to joint-
forming cells or chondrocytes within the joints (47). Specifically, TβRII signaling, by 
blocking critical inflammatory cytokines expression in the interzone, halts Collagen 2 
expression and induces interzone specific markers (i.e. Gdf5, Noggin). In mutant mice, lack 
of the TβRII expression in developing limbs, leads to disregulated levels of cytokine/
chemokines in the interzone (such as MCP-5 and IL-36α) which, in turn, block expression 
of interzone specific markers while increasing Collagen 2-expressing cells, with consequent 
accumulation of chondrocytes within the joint region and impaired of joint formation.
The activation of the inflammatory cytokine/chemokine cascade is associated with the more 
common forms of arthritis (100). The generally accepted hypothesis is that during the 
OA/RA process, the increased levels of cytokines and chemokines are the last step of a long 
lasting damage process that sees the joint as a passive target. To determine the role of TβRII 
signaling in joint homeostasis we generate a genetically modified mouse to tamoxifen 
induces, a Cre-conditional inactivation of floxed Tbfbr2 in osteochondro progenitors starting 
at postnatal day 3 of life (46). We found that postnatal TβRII signaling inactivation was 
associated with high expression of IL36α and MCP-5 (unpublished data) in the articular 
cartilage and synovium and progressive OA development(46). Blockage of IL36α signaling 
led to rescue of the OA phenotype(46). In a mouse model of post-traumatic OA, namely 
caused by a destabilization of the medial meniscus (DMM) surgically-induced after medial 
meniscotibial ligament transection, we found that an intense early cellular response of TβRII 
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positive cells that gradually decreased with OA progression and was associated with an 
increase of MCP-5 (101). Blockage of the MCP-5 signaling as well as implant of TβRII 
positive cells improved OA lesions and decreased subchondral bone reaction (101, 102). 
These findings suggest that TβRII signaling and cellular response is critical in joint 
development and it is an active mechanism to preserve joint homeostasis in adulthood. In 
this respect we provide a novel perspective to evaluate the OA process that results from the 
failure of an active cell joint population, expressing TβRII, to maintain a controlled cytokine 
environment rather than from the damage induced by a systemic influx of inflammatory 
cells and cytokines against a passive target (the joint).
CONCLUSIONS
Joint biology has been the subject of extensive research activity, and much has been learned 
about the structure and composition of articular cartilage, ligaments, synovium, and joint 
capsule, and the specific roles each of these tissues plays in joint function in developing and 
adult organisms Much is also known about susceptibility of joint tissues to damage and 
malfunction during natural aging and congenital or acquired skeletal conditions (20). 
Diseases that target and disrupt structure and function in the articular cartilage, synovium, 
meniscus and subchondral bone result in painful, debilitating and costly conditions for 
patients and society as a whole. The articular cartilage is avascular, and this presents 
limitations on its reparative capacity and for drug delivery. Joint homeostasis is maintained 
preserving the articular cells to proceed down the differentiation pathway that leads to 
chondrocyte hypertrophy and bone replacement such as it occurs in the growth plate 
cartilage. Many joint degenerating conditions may be seen as the failure of morphogenic 
factors to establish the correct microenvironment in cartilage and bone. Therefore, exploring 
how joints form can lead us to understand how cartilage and bone are damaged and develop 
drugs that are able to reactivate this developing mechanism. This information would have 
major biomedical relevance, as it could lead to novel repair strategies to restore joint 
function following trauma, as well as providing insight on the pathogenesis of acquired and 
inherited joint diseases.
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Figure 1. A model for the TβRII-mediated regulation of joint development
TβRII down-regulates MCP-5/IL-36α expressions in the interzone, allowing expression of 
key joint markers (such as Gdf5) while inhibiting Collagen2 expression. Lack of the TβRII 
signaling leads to up-regulation of interzone MCP-5/IL-36α with consequent lack of joint 
formation.
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Table 1
Joint Genetic Diseases
Location Gene locus Inheritance Phenotype Clinical Synopsis (skeletal)
17q22 Noggin Autosomal dominant Proximal symphalangism 1A Joint fusion
Proximal interphalangeal joint synostoses
Distal interphalangeal joint synostoses 
(occasional)
Carpal and tarsal bone fusion




Autosomal dominant Proximal symphalangism 1B Joint fusion
Distal interphalangeal joint fusions
Flat feet
Absence of the cuboid bone
Bone fusion (proximal/middle phalanges)
3p24.1 Tgfbr2 Loeys-Dietz syndrome type 2 















8q12.1 Jaws/Impad1 Autosomal recessive Chondrodysplasia with joint 
dislocations, GRAPP type
Joint dislocations
Shortening and deformity of the limbs
Brachydactyly
Longitudinal splitting of the proximal phalanx of 
forefinger
Splitting of the first metacarpal in two parts
Short stature
8q24.11 Ext1 Autosomal dominant Multiple cartilaginous exostoses, 
type 1
Cartilaginous protuberances at ends of long 
bones
Short metacarpal




Bilateral overriding of single toes




Degeneration of intervertebral disks
Fusion of vertebral bodies
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